Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pargellis

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structuresL Tong, S Pav, C Pargellis, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2007
Molecular basis of MAPK-activated protein kinase 2:p38 assemblyAndre White, Christopher A Pargellis, Joey M Studts, et al.
Journal of Enzyme Inhibition|January 1, 1997
Inhibition of dipeptidyl peptidase IV (CD26) by peptide boronic acid dipeptidesC A Pargellis, S J Campbell, S Pav, et al.
Cell|September 23, 1988
Autonomous DNA binding domains of lambda integrase recognize two different sequence familiesL Moitoso de Vargas, C A Pargellis, N M Hasan, et al.
Nature Structural Biology|April 1, 1997
A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocketL Tong, S Pav, D M White, et al.
Biochemistry|October 18, 1994
Determination of kinetic rate constants for the binding of inhibitors to HIV-1 protease and for the association and dissociation of active homodimerC A Pargellis, M M Morelock, E T Graham, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
The kinetics of binding to p38MAP kinase by analogues of BIRB 796John Regan, Christopher A Pargellis, Pier F Cirillo, et al.
The Journal of Biological Chemistry|August 5, 1991
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptaseK A Cohen, J Hopkins, R H Ingraham, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 proteaseD Lamarre, G Croteau, E Wardrop, et al.
Protein Science : a Publication of the Protein Society|January 1, 1997
Crystallization and preliminary crystallographic analysis of recombinant human P38 MAP kinaseS Pav, D M White, S Rogers, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structuresL Tong, S Pav, C Pargellis, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2007
Molecular basis of MAPK-activated protein kinase 2:p38 assemblyAndre White, Christopher A Pargellis, Joey M Studts, et al.
Journal of Enzyme Inhibition|January 1, 1997
Inhibition of dipeptidyl peptidase IV (CD26) by peptide boronic acid dipeptidesC A Pargellis, S J Campbell, S Pav, et al.
Cell|September 23, 1988
Autonomous DNA binding domains of lambda integrase recognize two different sequence familiesL Moitoso de Vargas, C A Pargellis, N M Hasan, et al.
Nature Structural Biology|April 1, 1997
A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocketL Tong, S Pav, D M White, et al.
Biochemistry|October 18, 1994
Determination of kinetic rate constants for the binding of inhibitors to HIV-1 protease and for the association and dissociation of active homodimerC A Pargellis, M M Morelock, E T Graham, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
The kinetics of binding to p38MAP kinase by analogues of BIRB 796John Regan, Christopher A Pargellis, Pier F Cirillo, et al.
The Journal of Biological Chemistry|August 5, 1991
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptaseK A Cohen, J Hopkins, R H Ingraham, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 proteaseD Lamarre, G Croteau, E Wardrop, et al.
Protein Science : a Publication of the Protein Society|January 1, 1997
Crystallization and preliminary crystallographic analysis of recombinant human P38 MAP kinaseS Pav, D M White, S Rogers, et al.
Pageof 4